Table 1 Demographic and clinical characteristics of the sample. Means ± standard deviations or N (%).
Characteristics | Total (N = 89) | Assigned Female at Birth (N = 69) | Assigned Male at Birth (N = 20) | Assigned Sex Diff. |
|---|---|---|---|---|
Age (years) | 29.5 ± 8.6 | 28.35 ± 7.8 | 33.35 ± 10.24 | p = 0.022 |
Race/Ethnicity (%) | p = 0.533 | |||
Asian | 7 (8%) | 6 (9%) | 1 (5%) | |
Black | 7 (8%) | 7 (10%) | 0 | |
Hispanic/Latino | 6 (7%) | 4 (6%) | 2 (10%) | |
Native American | 1 (1%) | 1 (1%) | 0 | |
White | 65 (73%) | 50 (72%) | 15 (75%) | |
Bi-/multiracial | 2 (2%) | 1 (1%) | 1 (5%) | |
Missing | 1 (1%) | 0 | 1 (5%) | |
Gender (%) | - | |||
Female | 65 (73%) | 65 (94%) | 0 | |
Male | 19 (21%) | 0 | 19 (95%) | |
Non-binary or gender non-conforming | 5 (6%) | 4 (6%) | 1 (5%) | |
Sex Assigned at Birth (female/male) | 69/20 | - | - | - |
Medication (%) | p’s > 0.289 | |||
SSRI | 24 (27%) | 19 (28%) | 5 (25%) | |
Mood Stabilizer | 7 (8%) | 6 (9%) | 1 (5%) | |
Antipsychotic | 1 (1%) | 1 (1%) | 0 | |
Benzodiazepine | 6 (7%) | 3 (4%) | 3 (15%) | |
SNRI | 4 (5%) | 4 (6%) | 0 | |
Tricyclic | 1 (1%) | 1 (1%) | 0 | |
Stimulant | 8 (9%) | 6 (9%) | 2 (10%) | |
Anti-hypertensive | 3 (3%) | 3 (4%) | 0 | |
Atypical Antidepressant | 8 (9%) | 7 (10%) | 1 (5%) | |
Anxiolytic | 6 (7%) | 4 (6%) | 2 (10%) | |
PACAP (pM) | 960.7 ± 766.9 | 1109.9 ± 786.9 | 445.9 ± 385.0 | p < 0.001 |
PTSD Diagnosis (%) | 59 (66.3%) | 49 (71%) | 10 (50%) | p = 0.080 |
CAPS Total | 29.0 ± 10.3 | 30.6 ± 10.1 | 23.3 ± 9.2 | p = 0.006 |
CAPS – Anxious Arousal | 3.1 ± 2.0 | 3.4 ± 2.1 | 2.8 ± 1.9 | p = 0.505 |
CAPS – Startle Response | 1.3 ± 1.2 | 1.4 ± 1.3 | 1.0 ± 1.1 | p = 0.189 |
LEC-5 Total | 13.2 ± 8.3 | 12.8 ± 8.4 | 14.4 ± 7.9 | p = 0.472 |
